Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Kingdom (3)
Vietnam (2)
STADA has appointed Nico Reinhold to Director Digital Communications
STADA Health Report on World Osteoporosis Day 2020: Europeans know too little about bone disease
To Russia, Poland, Ukraine and CIS countries
Acquisition of innovative therapy for treating advanced Parkinson’s disease
World Contraception Day on September 26 to raise awareness
Paulina Romaniszyn joins STADA as country head, Poland.
Fogstrup will take over management of STADAPHARM from September 1, 2020.
Nidda Healthcare GmbH sets cash compensation for the transfer of the shares of the minority shareholders of STADA Arzneimittel AG at 98.51 E…
Squeeze-out of minority shareholders in STADA Arzneimittel AG under stock corporation law
To a biosimilar candidate for Lucentis (ranibizumab) in the United States and Canada
March 2020 saw the highest production output in STADA’s 125-year history as the COVID-19 crisis significantly raised demand for critical med…
STADA has today closed a US$660 million transaction of a Russian brand portfolio from Takeda
Stephan Eder decides to join STADA mid-year ss Executive Vice President of Russia-CIS
STADA becomes a major Consumer Healthcare player
STADA has appointed Aidan Fry as Director of External Communications
STADA’s Philippines portfolio is strengthened with FERN C
Wolfgang Ollig to succeed Mark Keatley on 1 February 2020